Patent details

Basic Information

Publication number:

EP3897594

PCT Application Number:

US2019067591

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP198997074

PCT Publication Number:

WO2020132310

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

DEXTROAMPHETAMINE AND LISDEXAMFETAMINE TO REVERSE DEXMEDETOMIDINE SEDATION

French Title of Invention:

DEXTROAMPHÉTAMINE ET LISDEXAMFÉTAMINE POUR INVERSER LA SÉDATION PAR DEXMÉDÉTOMIDINE

German Title of Invention:

DEXTROAMPHETAMIN UND LISDEXAMFETAMIN ZUR UMKEHRUNG DER DEXMEDETOMIDINSEDATION

SPC Number:

Dates

Filing date:

19/12/2019

Grant date:

10/07/2024

EP Publication Date:

27/10/2021

PCT Publication Date:

25/06/2020

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

10/07/2024

EP B1 Publication Date:

10/07/2024

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

19/12/2024

Expiration date:

19/12/2039

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

03/07/2024

 

 

Name:

The General Hospital Corporation

Address:

55 Fruit Street, Boston, Massachusetts 02114, United States (US)

Inventor

1

Name:

JOHNSON-AKEJU, Oluwaseun

Address:

United States (US)

2

Name:

SOLT, Ken

Address:

United States (US)

Priority

Priority Number:

201862782097 P

Priority Date:

19/12/2018

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/137; A61P 25/26; A61K 31/165;

Publication

European Patent Bulletin

Issue number:

202428

Publication date:

10/07/2024

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages